Connecting Advisory Board’s 2026 State of the Industry to Data & AI-Driven Outcomes

Healthcare leaders are navigating one of the most dynamic and disruptive periods in recent memory. As we accelerate toward 2026, longstanding assumptions about who controls care delivery, how patients access services, and what drives clinical decision-making are rapidly shifting.

Join Advisory Board and Health Catalyst for a high-impact session that breaks down the most important industry forces shaping the year ahead—and what executives must do now to stay ahead of the curve.

Advisory Board will present key findings from its State of the Industry research, including:

• Safety Net Access Under Strain: A rapid shift toward a “utilitarian patchwork” of community access driven by shrinking coverage, rising uncompensated care, and rural provider vulnerability.
• The Limits of Generic Scale: Payers increasingly delegating to niche experts amid GLP-1 cost pressures, behavioral health complexity, and growing scrutiny of utilization management.
• The Rise of New Clinical Power Brokers: How AI vendors, DTC brands, social platforms, and nontraditional practice owners are influencing treatment decisions and patient expectations.

Kevin Freeman, Chief Commercial Officer at Health Catalyst, will connect these trends to real-world client outcomes—showing how leading health systems are using data, analytics, scalability, and operational transformation to address these emerging challenges.

‍